A patient came to see me earlier this year who had been functionally disabled for fourteen months following an otherwise unremarkable COVID infection. She was 39, previously fit, ran half marathons, worked full-time as a project manager. Post-infection she could not stand at a kitchen counter for ten minutes without her heart rate climbing to 130, could not finish a workday without crashing, and had cognitive fog severe enough that she had taken medical leave. She had been told by three different providers that there was nothing specifically to do for long COVID and that she should rest and wait it out.
Long COVID is real, the underlying biology is now reasonably well-understood, and IV therapy can play a useful role in the recovery — but only when it is matched to the actual mechanism that is driving symptoms in a particular patient. The marketing around "long COVID IV cocktails" significantly overstates what an infusion alone will do. The clinical reality is more nuanced and, in my experience, more useful when it is approached honestly.
What is actually happening in long COVID
The post-acute sequelae of COVID infection — what most people now call long COVID — appears to be driven by several distinct mechanisms that often coexist in the same patient. The mechanisms that show up most consistently in the literature and in the patients I see are persistent low-grade inflammation, mitochondrial dysfunction, autonomic nervous system dysregulation (most commonly POTS-like dysautonomia), microvascular and endothelial damage, viral persistence in tissue reservoirs in some patients, immune dysregulation including autoantibody production, and gut dysbiosis with associated barrier dysfunction.
Different patients have different mixes of these mechanisms. A patient whose dominant problem is dysautonomia presents differently from a patient whose dominant problem is mitochondrial dysfunction, and the right treatment plan looks different for each. There is no single long COVID protocol because there is no single long COVID phenotype.
This is the part the marketing tends to skip. A standard "long COVID IV" sold as a single product cannot match the mechanism it is supposed to address because the mechanism is different in different patients.
Where IV therapy actually helps — the bioavailability and pharmacology argument
IV hydration therapy bypasses the gut and delivers nutrients, electrolytes, and certain medications directly into the bloodstream. The advantage over oral intake is bioavailability. For most nutrients, oral absorption ranges from 5 to 60 percent depending on the nutrient, the gut state, and the dose. For some compounds — high-dose vitamin C, glutathione, NAD+ — oral absorption is essentially negligible at therapeutic doses. IV delivery achieves serum concentrations that oral simply cannot.
In the long COVID context, the components that have a defensible mechanism include intravenous fluids and electrolytes for the volume expansion that dysautonomia patients often benefit from, B-complex and B12 for mitochondrial cofactor support, magnesium because it is required for hundreds of enzymatic reactions including ATP production and is commonly depleted in chronic illness, vitamin C at moderate doses for antioxidant support, glutathione as the master cellular antioxidant, and in selected cases NAD+ as a mitochondrial substrate.
I want to be clear about what this does and does not accomplish. IV therapy is supportive. It supplies cofactors and substrates that the recovering system needs. It does not eliminate viral reservoirs, it does not directly treat dysautonomia, and it does not by itself reverse the underlying immune dysregulation. What it does is give the body better raw materials to work with while the underlying mechanisms are addressed through other means.
What I look for before recommending an IV protocol
When a patient comes in asking about IV therapy for long COVID, I do not start with the IV. I start with the workup, because the right protocol depends on what is actually wrong.
The labs I want to see include a CBC with differential and a comprehensive metabolic panel, ferritin and iron studies, B12 and folate, vitamin D, magnesium (RBC magnesium is more accurate than serum), high-sensitivity CRP, ESR, a thyroid panel including free T3 and reverse T3, fasting insulin and glucose, and a hormone panel — because chronic illness suppresses the HPA and HPG axes, and untreated hormonal suppression will keep a patient stuck regardless of what else is being done.
For dysautonomia symptoms specifically, I want orthostatic vitals — supine, sitting, standing at one minute and three minutes. A heart rate that climbs by more than 30 beats per minute on standing without a corresponding blood pressure change suggests POTS, which changes the conversation significantly.
I also take a careful history about the trajectory of symptoms — what came on first, what has gotten worse, what triggers exacerbation, whether post-exertional malaise is a feature. Post-exertional malaise — symptoms worsening for 24 to 72 hours after exertion that previously would have been tolerated — is a clinical hallmark and changes how aggressively a patient should be pushed in any rehabilitative direction.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
Once that picture is in hand, the IV protocol is matched to it. A patient with documented magnesium deficiency, mitochondrial symptoms, and post-exertional malaise gets a different recipe than a patient with predominantly inflammatory and gut symptoms.
A reasonable IV protocol for long COVID, in context
In patients where the workup supports it, the protocol I tend to use as a starting point is a series of weekly or biweekly infusions over six to eight weeks, then reassessment. The base is normal saline at one liter, which provides the volume expansion that helps dysautonomia patients tolerate upright posture better. Onto that we add a B-complex with extra B12, magnesium sulfate at a dose appropriate to the patient's renal function, vitamin C at a moderate dose (typically 5 to 10 grams, not the very high doses used in oncology research which require G6PD screening and a different consent conversation), and glutathione pushed toward the end of the infusion because of its short half-life in solution.
For patients with significant cognitive symptoms and adequate clinical justification, NAD+ infusions can be added. NAD+ is uncomfortable for most patients at therapeutic doses — chest tightness, flushing, nausea — and requires a slower infusion rate that takes two to four hours. It is not a casual infusion and it is not appropriate as a first-line wellness add-on. In long COVID patients with mitochondrial features, in selected cases, it has clinical utility.
What I do not include in this protocol: trace minerals beyond magnesium without documented deficiency, "amino acid blends" without specific indication, "immune support cocktails" with no defined mechanism, and proprietary blends sold under brand names that do not disclose dosing.
What the IV alone will not do
This is the conversation I have with every patient before we start. The IV is one piece of the recovery plan. It is not the recovery plan.
The recovery plan also has to address the autonomic dysregulation directly, usually with graduated supine-to-upright reconditioning, compression garments, increased salt and fluid intake, and in selected cases medications managed by their primary or a cardiologist. It has to address sleep, because non-restorative sleep keeps inflammation elevated and prevents recovery. It has to address the hormonal axis, because chronic illness suppresses both the HPA and HPG axes, and patients stuck in suppressed cortisol and suppressed sex hormones will not recover effectively until the axes are supported — which often involves hormone optimization for women and the equivalent for men. It has to address the gut, because intestinal barrier dysfunction maintains the inflammatory loop. It has to address pacing, because patients with post-exertional malaise who push through symptoms get worse, not better.
In the patients I see who recover meaningfully, the IV is a useful piece of a plan that also addresses all of these. In the patients who only do the IV, the gains are often real but limited and tend to wane between infusions because nothing else has changed.
How I evaluate someone for the program
The first conversation is a comprehensive wellness assessment, not an IV booking. I want to take a real history, see the labs that exist, identify the labs that are still needed, and develop a plan that includes the IV component appropriately rather than as a stand-alone purchase.
For patients whose labs and history support it, the IV series is built into a broader plan and reassessed at four weeks and again at eight weeks. We track symptoms specifically — not just "feeling better" but specific objective markers: maximum tolerated upright time, cognitive performance on standardized tasks, post-exertional malaise frequency and severity, sleep quality. If the IV piece is helping, those markers move. If they do not move after a reasonable trial, we stop and re-strategize rather than continuing to infuse on the assumption that more will eventually work.
I will recommend against IV therapy in patients whose presenting picture does not support it. A patient whose long COVID symptoms are predominantly hormonal suppression with normal mineral and vitamin status does not need IV nutrients. They need hormone optimization and time. Spending money on infusions in that scenario is not in the patient's interest.
What to do next if this is your situation
If you have been struggling with post-COVID symptoms long enough that you are considering IV therapy, the right starting point is the workup, not the infusion. Schedule an infusion consultation through the booking portal — or call either the Columbus IV clinic or Warner Robins IV clinic and ask for a long COVID evaluation specifically so the right time gets allocated.
Bring everything you have — prior labs, medication list, a written timeline of symptoms with dates, any orthostatic readings you may have taken at home. We will look at the picture, identify what is driving the symptoms, and decide together whether IV therapy is part of the right plan or whether the time and money would be better spent elsewhere first. Honest answers either way.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.